Extent of disease on high-resolution computed tomography lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung disease
Owen A Moore, Nicole Goh, Tamera Corte, Hannah Rouse, Oliver Hennessy, Vivek Thakkar, Jillian Byron, Joanne Sahhar, Janet Roddy, Eli Gabbay, Peter Youssef, Peter Nash, Jane Zochling, Susanna M Proudman, Wendy Stevens, Mandana Nikpour
Rheumatology | OXFORD UNIV PRESS | Published : 2013
Related Projects (1)
This work was supported by a University of Melbourne Early Career Research Grant (M.N. and O.A.M.); Scleroderma Australia; Arthritis Australia; Actelion Australia; Bayer; CSL Biotherapies; GlaxoSmithKline Australia; and Pfizer.